PR Newswire PharmaOriginal article
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
Data ReadoutpositiveMyriadPositive
AI Analysis
Summary
Aroa Biosurgery's peer-reviewed 411-patient study demonstrates low infection rates with Myriad bioscaffold in complex soft tissue reconstruction, representing the largest published prospective bioscaffold analysis in the indication.
Clinical Trial Data
Primary Endpoint
Met
Patients
411
Outcome Details
411-patient peer-reviewed study reports low infection rates with Myriad in complex soft tissue reconstruction
Importance:6/10
Sentiment:
0.70
soft tissue regenerationbioscaffoldregistry analysisclinical datainfection rates
Related Companies
Read the original article
Published by PR Newswire Pharma on September 7, 2026 12:46 AM